Evidence map›Paper›PMID 40477027›Full record

ReviewActa epileptologica2020

Epilepsy control during an epidemic: emerging approaches and a new management framework.

Deng Chen, Lina Zhu, Xin Lin, Zhen Hong, Shichuo Li, Ling Liu, Dong Zhou

Abstract readReview
In one paragraph

Review in Acta epileptologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deng ChenDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, 610041 China.
Lina ZhuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, 610041 China.
Xin LinDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, 610041 China.
Zhen HongDepartment of Neurology, Shanghai Huashan Hospital, Fudan University, Shanghai, 200040 China.
Shichuo LiChina Association Against Epilepsy (CAAE), Beijing, 10044 China.
Ling LiuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, 610041 China.
Dong ZhouDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, 610041 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemics are a big threat to world health. The ongoing pandemic of corona virus disease 2019 (COVID-19) has caused a series of challenges to public health. One such challenge is the management of chronic diseases such as epilepsy during an epidemic event. Studies on this topic are rather limited and the related medical practice is full of uncertainty. Here we review recent development of potential approaches for epilepsy control during an epidemic and propose a new three-level management framework to address these challenges.

Indexed as

Disease controlEpidemicEpilepsy

Identifiers

PMID40477027
PMCPMC7215138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.